4 ms·
Perhaps more countries should follow Thailand's approach: On January 25, 2007, Thailand’s interim government issued compulsory licenses–which require
by wsc981 7y ago
Perhaps more countries should follow Thailand's approach:
On January 25, 2007, Thailand’s interim government issued compulsory licenses–which require
manufacturers to license generic versions of their patented drugs–for two Western medicines:
Kaletra, an advanced anti-AIDS medicine manufactured by Abbott; and Plavix, a blood-thinning
treatment to help prevent heart disease, produced by the France-based Sanofi-Aventis and U.S.
firm Bristol-Myers Squibb. These attacks were preceded in November 2006 by a violation of
Merck’s patent on the anti-AIDS drug Stocrin.[5] The government threatened to break
patents on eleven more drugs.[6] Explaining the rationale behind Thailand’s decision, health
minister Mongkol Na Songkhla said that “the move is permissible under international trade
rules in the event of national public health emergencies. . . . We have to do this because we
don’t have enough money to buy safe and necessary drugs for the people under the government’s
universal health scheme.”[7]
Source: http://www.aei.org/publication/thailand-and-the-drug-patent-wars/ http://www.aei.org/publication/thailand-and-the-drug-patent-...
Perhaps "evergreening" is also an issue in the USA that might keep prices high for a long time?
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680578/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680578/
- andy_ppp 7y agoQuoting like this makes it impossible to read on mobile. Not your fault but “speech marks” are fine.
- WillDaSilva 7y agoAre you using an app such as Materialistic or Hews, or just using your browser? For what it's worth I don't recall any problems reading quote blocks on Materialistic.
- rabbitonrails 7y agoLike most people, I am reading on a mobile browser and cannot read this quote.
- bobwaycott 7y agoThe above quote, for mobile users: > On January 25, 2007, Thailand’s interim government issued compulsory licenses–which require manufacturers to license generic versions of their patented drugs–for two Western medicines: Kaletra, an advanced anti-AIDS medicine manufactured by Abbott; and Plavix, a blood-thinning treatment to help prevent heart disease, produced by the France-based Sanofi-Aventis and U.S. firm Bristol-Myers Squibb. These attacks were preceded in November 2006 by a violation of Merck’s patent on the anti-AIDS drug Stocrin.[5] The government threatened to break patents on eleven more drugs.[6] Explaining the rationale behind Thailand’s decision, health minister Mongkol Na Songkhla said that “the move is permissible under international trade rules in the event of national public health emergencies. . . . We have to do this because we don’t have enough money to buy safe and necessary drugs for the people under the government’s universal health scheme.”